SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-125943
Filing Date
2024-12-05
Accepted
2024-12-05 17:05:44
Documents
2
Period of Report
2024-12-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2430303-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2430303-2_4seq1.xml 4 3822
2 EXHIBIT 24 tm2430303d2_ex24.htm EX-24 7441
  Complete submission text file 0001104659-24-125943.txt   13166
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SELLAS LIFE SCIENCES GROUP, INC. 2000 CROW CANYON PLACE, SUITE 380 SAN RAMON CA 94583
Business Address
Stergiou Angelos M. (Reporting) CIK: 0001724253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 241529838